Comment: While many commenters indicated that our proposed changes to the HPT requirements outlined in the CY 2026 OPPS/ASC proposed rule and/or the HPT requirements in general are burdensome, as discussed in prior sections of this final rule with comment period, only several commenters commented on our specific burden estimates for these information collections
albicans and gut bacteria are still lacking
Pricing may vary based on provider evaluation, pharmacy preparation, dose, treatment length, and clinical eligibility
Therefore, this article aims to address that gap by investigating the governance and political conditions necessary for developing CBCA in cities, using Paris and Gothenburg as case studies
These (and others) are all important to the recovery process, so it's important to get the balance right